Zenas BioPharma Inc.

NASDAQ: ZBIO · Real-Time Price · USD
16.82
0.06 (0.36%)
At close: Aug 15, 2025, 3:59 PM
17.00
1.07%
After-hours: Aug 15, 2025, 05:40 PM EDT

Zenas BioPharma Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
Revenue
5M 50M n/a
Cost of Revenue
137K 113K 78K
Gross Profit
5M 50M -78K
Operating Income
-163.89M -37.15M -76.2M
Interest Income
n/a n/a n/a
Pretax Income
-156.56M -36.82M -119.28M
Net Income
-156.99M -37.12M -119.28M
Selling & General & Admin
29.75M 17.11M 13.51M
Research & Development
139.14M 60.03M 61.69M
Other Expenses
n/a 10M 1M
Operating Expenses
168.89M 87.15M 76.2M
Interest Expense
n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a
Cost & Expenses
168.89M 87.15M 76.2M
Income Tax Expense
429K 301K n/a
Shares Outstanding (Basic)
41.79M 38.32M 38.32M
Shares Outstanding (Diluted)
41.79M 38.32M 38.32M
EPS (Basic)
-3.76 -0.97 -3.11
EPS (Diluted)
-3.76 -0.97 -3.11
EBITDA
-163.75M -27.03M -75.12M
EBIT
-163.89M -27.15M -75.2M
Depreciation & Amortization
137K 113K 78K